A case report of manic episode following SARS-CoV-2 infection

Mithun Devasia; Anil Prabhakaran; S Rithwik

doi:10.30834/KJP.34.1.2021.264

Authors

Mithun Devasia Junior Resident, Dept of Psychiatry, Medical College, Thiruvananthapuram
Anil Prabhakaran Professor & HOD, Department of Psychiatry, Government Medical college, Thiruvananthapuram
S Rithwik Junior Resident, Department of Psychiatry, Government Medical college, Thiruvananthapuram

DOI:

https://doi.org/10.30834/KJP.34.1.2021.264

Keywords:

: COVID-19, manic episode, SARS CoV-2, EEG

Abstract

The novel coronavirus infection has been associated with various neuropsychiatric sequelae, including manic episodes, but only a few cases have been described in the literature. Here we present a case of a manic episode in an individual following COVID-19 infection, probably linked to the virus. This case report highlights the need to identify and assess various neuropsychiatric manifestations of COVID-19 and the need for further research on its manifestations, biological mechanisms, and long-term sequelae.

References

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurology. 2020 Aug 1;77(8):1018-27.

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatr. 2020;7:611–627. doi: 10.1016/S2215-0366(20)30203-0.

Ortiz A, Berlanga C, Gutierrez DMA case of clarithromycin-induced manic episode (antibiomania). International Journal of Neuropsychopharmacology (2004);7:99–100.

Kubota T, Gajera PK, Kuroda N. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav. 2021 02;115:107682.

Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. Eur J Radiol. 2020 Dec; 133:109393.

Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020 Jul 1; 87:34–9.

Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS chemical neuroscience. 2020 Mar 13;11(7):995-8.

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570. PMID: 15141377; PMCID: PMC7167720.

Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother. 2021 Mar;135:111200.

Benros ME, Waltoft BL, Nordentoft M, Østergaard SD, Eaton WW, Krogh J, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013 Aug 1;70(8):812-20.